SuperworthValion Bio market cap VBIO
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $834.3K
- Highest close in our data
- $430.2M
- Aug 2022
Valion Bio is worth $834.3K at the close on Oct 23, 2026, at $0.94 a share.
That is down 73% over the last year.
Its highest close in our data was $430.2M in Aug 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $834.3K | $609.4K | $3.8M | −71% |
| 2025 | $2.8M | $1.7M | $80.2M | −93% |
| 2024 | $41.8M | $12.6M | $53.8M | −7% |
| 2023 | $44.9M | $18.9M | $149M | −57% |
| 2022 | $105.3M | $102M | $430.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Valion Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| VBIOValion Bio | $834.3K |
| NXTSNexentis Technologies | $761.8K |
| LABTLakewood-Amedex Biotherapeutics | $734.6K |
| JAGXJaguar Health | $702.9K |
| DCOYDecoy Therapeutics | $635.5K |
| SBFMSunshine Biopharma | $581.6K |
| ARTLArtelo Biosciences | $1.3M |
| LNAILunai Bioworks | $1.5M |
| GNPXGenprex | $1.5M |
| GOVXGeoVax Labs | $1.5M |
| ONCOOnconetix | $1.7M |
| Peer median | $1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Valion Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.